Skip to search boxSkip to navigationSkip to main content

Lack of an Association Between Household Air Pollution Exposure and Previous Pulmonary Tuberculosis

  • Dennis Emuron
    ,
  • Trishul Siddharthan
    ,
  • Brooks Morgan
    ,
  • Suzanne L. Pollard
    ,
  • Matthew R. Grigsby
    ,
  • Dina Goodman
*Corresponding author for this work
  • Johns Hopkins University School of Medicine
    ,
  • b
    ,
  • Instituto de Efectividad Clínica y Sanitaria (IECS)
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • Universidad Peruana Cayetano Heredia
    ,
  • Faculty of Health
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 793-801 (9 pages)

Journal (Volume, Issue Number)

Lung (Volume 197, Issue 6)

Publication milestones

  • Published - 01/12/2019

Publication status

Published - 01/12/2019

ISSN

0341-2040

Publication IDs

  • Scopus: 85074431286
  • PubMed: 31583454

Abstract

Context: Observational studies investigating household air pollution (HAP) exposure to biomass fuel smoke as a risk factor for pulmonary tuberculosis have reported inconsistent results. Objective: To evaluate the association between HAP exposure and the prevalence of self-reported previous pulmonary tuberculosis. Design: We analyzed pooled data including 12,592 individuals from five population-based studies conducted in Latin America, East Africa, and Southeast Asia from 2010 to 2015. We used multivariable logistic regression to model the association between HAP exposure and self-reported previous pulmonary tuberculosis adjusted for age, sex, tobacco smoking, body mass index, secondary education, site and country of residence. Results: Mean age was 54.6 years (range of mean age across settings 43.8–59.6 years) and 48.6% were women (range of % women 38.3–54.5%). The proportion of participants reporting HAP exposure was 38.8% (range in % HAP exposure 0.48–99.4%). Prevalence of previous pulmonary tuberculosis was 2.7% (range of prevalence 0.6–6.9%). While participants with previous pulmonary tuberculosis had a lower pre-bronchodilator FEV1 (mean − 0.7 SDs, 95% CI − 0.92 to − 0.57), FVC (− 0.52 SDs, 95% CI − 0.69 to − 0.33) and FEV1/FVC (− 0.59 SDs, 95% CI − 0.76 to − 0.43) as compared to those who did not, we did not find an association between HAP exposure and previous pulmonary tuberculosis (adjusted odds ratio = 0.86; 95% CI 0.56–1.32). Conclusions: There was no association between HAP exposure and self-reported previous pulmonary tuberculosis in five population-based studies conducted worldwide.

Funding Details

We would like to thank Dr. Shakir Hossen for his independent review of the statistics and development of figures. These studies were sponsored and funded by the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institute of Health in the United States, under contracts HHSN268200900029C, HHSN268200900032C, and HHSN26820900033C. FRESH AIR Uganda was done by the University Medical Centre Groningen (Netherlands) in close collaboration with Makerere University (Uganda) and the Leiden University Medical Centre (Netherlands). It was funded by the International Primary Care Respiratory Group (UK), supported by an unrestricted grant from Mundipharma International. WC is additionally supported under UM1HL134590. TS was supported by a National Research Service Award through the National Institute of Environmental Health Sciences of the National Institutes of Health (1F32ES028577). AR was supported by the National Institutes of Health Office of the Director, Fogarty International Centre and National Heart, Blood, and Lung Institute through the International Clinical Research Fellows Program at Vanderbilt University (R24TW007988) and the American Relief and Recovery Act. RJ was supported by the Applied Research Collaboration South West Peninsula. We would like to thank Dr. Shakir Hossen for his independent review of the statistics and development of figures. These studies were sponsored and funded by the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institute of Health in the United States, under contracts HHSN268200900029C, HHSN268200900032C, and HHSN26820900033C. FRESH AIR Uganda was done by the University Medical Centre Groningen (Netherlands) in close collaboration with Makerere University (Uganda) and the Leiden University Medical Centre (Netherlands). It was funded by the International Primary Care Respiratory Group (UK), supported by an unrestricted grant from Mundipharma International. WC is additionally supported under UM1HL134590. TS was supported by a National Research Service Award through the National Institute of Environmental Health Sciences of the National Institutes of Health (1F32ES028577). AR was supported by the National Institutes of Health Office of the Director, Fogarty International Centre and National Heart, Blood, and Lung Institute through the International Clinical Research Fellows Program at Vanderbilt University (R24TW007988) and the American Relief and Recovery Act. RJ was supported by the Applied Research Collaboration South West Peninsula.
FundersFunding numbers
American Relief and Recovery Act
-
National Institutes of Health Office of the Director, Fogarty International Centre
-
NIH
HHSN268200900032C, HHSN26820900033C
NHLBI
-
FIC
R24TW007988
NIEHS
1F32ES028577
VU
-
Mundipharma International
UM1HL134590
LUMC
-
UMCG
-
MAK
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
76
Citations
5

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well